References
- European Association for the Study of the Liver. Electronic address: [email protected], EASL clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 2018;69(1):182–236.
- Thompson SM, Welch BT, Kurup AN. Ablation for oligometastatic colorectal carcinoma in extrahepatic, extrapulmonary sites. Int J Hyperthermia. 2022;39(1):633–638.
- Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68(2):723–750.
- Filippiadis DK, Efthymiou E, Palialexis K, et al. Interventional oncology procedures for breast cancer metastatic disease: current role and clinical applications. Diagn Interv Radiol. 2022;28(3):249–256.
- Zhang ZY, Jiang AN, Yang W, et al. Percutaneous radiofrequency ablation is an effective method for local control of liver metastases from lung cancer. Front Oncol. 2022;12:877273.
- Mansur A, Garg T, Shrigiriwar A, et al. Image-guided percutaneous ablation for primary and metastatic tumors. Diagnostics . 2022;12(6):1300.
- Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv238–iv255.
- Ahmed M, Solbiati L, Brace CL, Guided tumor ablation:standardization of terminology and reporting criteria—a 10-year update. Radiology. 2014;273(1):241–260.
- Wang Z, Liu M, Zhang DZ, et al. Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3–5-cm HCC. Hepatology. 2022;76(1):66–77.
- Llovet JM, De Baere T, Kulik L, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18(5):293–313.
- Zhu F, Rhim H. Thermal ablation for hepatocellular carcinoma: what’s new in 2019. Chin Clin Oncol. 2019;8(6):58–58.
- Yu J, Yu XL, Han ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut. 2017;66(6):1172–1173.
- Cavagnaro M, Pinto R, Lopresto V. Numerical models to evaluate the temperature increase induced by ex vivo microwave thermal ablation. Phys Med Biol. 2015;60(8):3287–3311.
- Ji Z, Brace CL. Expanded modeling of temperature-dependent dielectric properties for microwave thermal ablation. Phys Med Biol. 2011;56(16):5249–5264.
- Wang X, Gao H, Wu S, et al. RF ablation thermal simulation model: parameter sensitivity analysis. Technol Health Care. 2018;26(S1):179–192.
- O’Rourke AP, Lazebnik M, Bertram JM, et al. Dielectric properties of human normal, malignant and cirrhotic liver tissue: in vivo and ex vivo measurements from 0.5 to 20 GHz using a precision open-ended coaxial probe. Phys Med Biol. 2007;52(15):4707–4719.
- Sy S, Huang S, Wang YX, et al. Terahertz spectroscopy of liver cirrhosis: investigating the origin of contrast. Phys Med Biol. 2010;55(24):7587–7596.
- Danielsen KV, Wiese S, Busk T, et al. Cardiovascular mapping in cirrhosis from the compensated stage to hepatorenal syndrome: a magnetic resonance study. Am J Gastroenterol. 2022;117(8):1269–1278.
- Zhang XQ, Zheng RQ, Jin JY, et al. US shear-wave elastography dispersion for characterization of chronic liver disease. Radiology. 2022;305(3):597–605.
- Huang X, Zhou Y, Wang C, et al. Development of a novel MR-conditional microwave needle for MR-guided interventional microwave ablation at 1.5T. Magn Reson Med. 2022;88(4):1886–1900.
- Hensen B, Drenkmann U, Frericks B, et al. Detection of ablation boundaries using different MR sequences in a swine liver model. Cardiovasc Intervent Radiol. 2022;45(7):1010–1018.
- Ding W, Yu J, Liu F, et al. Percutaneous microwave ablation versus robot-assisted hepatectomy for early hepatocellular carcinoma: a real-world single-center study. Dig Liver Dis. 2022;54(2):243–250.
- Nieuwenhuizen S, Dijkstra M, Puijk RS, et al. Microwave ablation, radiofrequency ablation, irreversible electroporation, and stereotactic ablative body radiotherapy for intermediate size (3–5 cm) unresectable colorectal liver metastases: a systematic review and meta-analysis. Curr Oncol Rep. 2022;24(6):793–808.
- Xu Y, Shen Q, Wang N, et al. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma. Chin J Cancer. 2017;36(1):14.
- Ren H, Guo W, Sam Ge S, et al. Coverage planning in computer-assisted ablation based on genetic algorithm. Comput. Biol. Med. 2014;49:36–45.
- Ai H, Wu S, Gao H, et al. Temperature distribution analysis of tissue water vaporization during microwave ablation: experiments and simulations. Int J Hyperthermia. 2012;28(7):674–685.
- Heerink WJ, Solouki AM, Vliegenthart R, et al. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis. Eur Radiol. 2018;28(8):3228–3236.
- Ruiter SJS, de Jong JE, Pennings JP, et al. Comparison of two 2.45-GHz microwave ablation devices with respect to ablation zone volume in relation to applied energy in patients with malignant liver tumours. Cancers. 2022;14(22):5570.
- Sakamoto Y, Kokudo N, Kawaguchi Y, et al. Clinical anatomy of the liver: review of the 19th meeting of the Japanese research society of clinical anatomy. Liver Cancer. 2017;6(2):146–160.
- Ziessman HA, Thrall JH, Gyves JW, et al. Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy. J. Nucl. Med. 1983;24(10):871–875.